The test will be featured in posters presented at the 2018 San Antonio ... pharmaceutical and biotech companies and advances the seminal work in ...
News
- Insight Genetics Launches First-of-its-kind Test for Triple Negative Breast Cancer
- Escalating trade dispute looms over Trump, Xi meeting
... remains committed to becoming a global competitor in cutting-edge technologies such as robotics, artificial intelligence and biotechnology by 2025.
- New therapies unveiled at San Antonio breast cancer conference
According to the San Antonio Chamber of Commerce's Healthcare + Bioscience Economic Impact Study 2018, the health and bioscience sector ...
- Initial public offerings scheduled to debut next week
Business: Phase 2 biotech targeting acute ischemic stroke and chronic ... Business: Preclinical biotech developing immunotherapies for solid tumors ...
- Fear that uproar over gene-edited babies could block science
But there's significant discomfort, if not complete opposition, to enhancement uses," said Josephine Johnston, an expert on biomedical ethics and ...